These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6157783)

  • 1. Deficient intestinal absorption of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies.
    Koskiniemi ML
    J Neurol Sci; 1980 Jul; 47(1):1-6. PubMed ID: 6157783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-tryptophan-carbidopa trial in patients with long-standing progressive myoclonus epilepsy.
    Leino E; MacDonald E; Airaksinen MM; Riekkinen PJ; Salo H
    Acta Neurol Scand; 1981 Aug; 64(2):132-41. PubMed ID: 6172951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan.
    Pranzatelli MR; Tate E; Huang Y; Haas RH; Bodensteiner J; Ashwal S; Franz D
    Epilepsia; 1995 Aug; 36(8):783-91. PubMed ID: 7543407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with progressive myoclonus epilepsy.
    Leino E; MacDonald E; Airaksinen MM; Riekkinen PJ
    Acta Neurol Scand; 1980 Jul; 62(1):41-54. PubMed ID: 6163302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of indican in progressive myoclonus epilepsy without Lafora bodies. The effect of sodium valproate.
    Koskiniemi M; Palo J
    J Neurol Sci; 1978 Dec; 39(2-3):235-9. PubMed ID: 105091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient effect of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies: clinical and electrophysiological study.
    Koskiniemi M; Hyyppä M; Sainio K; Salmi T; Sarna S; Uotila L
    Epilepsia; 1980 Aug; 21(4):351-7. PubMed ID: 6772434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baltic myoclonus.
    Koskiniemi ML
    Adv Neurol; 1986; 43():57-64. PubMed ID: 2418650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Findings in routine laboratory examination in progressive myoclonus epilepsy.
    Koskiniemi M
    Acta Neurol Scand; 1975 Jan; 51(1):12-20. PubMed ID: 804227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal absorption of L-tryptophan in scleroderma.
    Stachow A; Jablońska S; Skiendzielewska A
    Acta Derm Venereol; 1976; 56(4):257-64. PubMed ID: 60020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan metabolism in liver cirrhosis: influence of oral antibiotics on neuropsychiatric symptoms.
    Yoshida K; Hirayama C
    Tohoku J Exp Med; 1984 Jan; 142(1):35-41. PubMed ID: 6202023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age on serum tryptophan and urine indican in adults given a tryptophan load test.
    Smith DF
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):55-8. PubMed ID: 6802644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole levels in human lumbar and ventricular cerebrospinal fluid and the effect of L-tryptophan administration.
    Koskiniemi M; Laakso J; Kuurne T; Laipio M; Härkönen M
    Acta Neurol Scand; 1985 Feb; 71(2):127-32. PubMed ID: 2580417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhibition of serotonin synthesis on 5-hydroxyindoleacetic acid excretion, in healthy subjects.
    Alfieri AB; Cubeddu LX
    J Clin Pharmacol; 1994 Feb; 34(2):153-7. PubMed ID: 7512997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients.
    Norio R; Koskiniemi M
    Clin Genet; 1979 May; 15(5):382-98. PubMed ID: 109240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan.
    Green AR; Aronson JK; Curzon G; Woods HF
    Br J Clin Pharmacol; 1980 Dec; 10(6):603-10. PubMed ID: 6162471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers.
    Williams WA; Shoaf SE; Hommer D; Rawlings R; Linnoila M
    J Neurochem; 1999 Apr; 72(4):1641-7. PubMed ID: 10098872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD
    Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies.
    Mervaala E; Andermann F; Quesney LF; Krelina M
    Neurology; 1990 Jan; 40(1):53-6. PubMed ID: 2104965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myoclonic epilepsies in infancy].
    Palencia R
    Rev Neurol; 2000 Jun; 30 Suppl 1():S15-24. PubMed ID: 10904965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Startle Response in Progressive Myoclonic Epilepsy.
    Kızıltan ME; Gündüz A; Coşkun T; Delil Ş; Pazarcı N; Özkara Ç; Yeni N
    Clin EEG Neurosci; 2017 Mar; 48(2):123-129. PubMed ID: 27170668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.